263 related articles for article (PubMed ID: 14746510)
21. Antisense protein kinase A RI alpha-induced tumor reversion: portrait of a microarray.
Cho-Chung YS
Biochim Biophys Acta; 2004 Mar; 1697(1-2):71-9. PubMed ID: 15023351
[TBL] [Abstract][Full Text] [Related]
22. An overview of sugar-modified oligonucleotides for antisense therapeutics.
Prakash TP
Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654
[TBL] [Abstract][Full Text] [Related]
23. Antisense oligonucleotides: from design to therapeutic application.
Chan JH; Lim S; Wong WS
Clin Exp Pharmacol Physiol; 2006; 33(5-6):533-40. PubMed ID: 16700890
[TBL] [Abstract][Full Text] [Related]
24. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
25. Monitoring antisense oligodeoxynucleotide activity in hematopoietic cells.
Sokol DL; Gewirtz AM
Methods; 1999 Mar; 17(3):219-30. PubMed ID: 10080907
[TBL] [Abstract][Full Text] [Related]
26. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
[TBL] [Abstract][Full Text] [Related]
27. Antisense oligonucleotides in the study of central mechanisms of the cardiovascular regulation.
Culman J
Exp Physiol; 2000 Nov; 85(6):757-67. PubMed ID: 11187969
[TBL] [Abstract][Full Text] [Related]
28. Oligonucleotide therapy.
Crooke ST
Curr Opin Biotechnol; 1992 Dec; 3(6):656-61. PubMed ID: 1369122
[TBL] [Abstract][Full Text] [Related]
29. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation.
Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M
Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084
[TBL] [Abstract][Full Text] [Related]
30. Peptide nucleic acids as therapeutic agents.
Nielsen PE
Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
[TBL] [Abstract][Full Text] [Related]
31. Antisense imaging: and miles to go before we sleep?
Lewis MR; Jia F
J Cell Biochem; 2003 Oct; 90(3):464-72. PubMed ID: 14523980
[TBL] [Abstract][Full Text] [Related]
32. Towards genomic drug therapy with antisense oligonucleotides.
Lönnberg H; Vuorio E
Ann Med; 1996 Dec; 28(6):511-22. PubMed ID: 9017110
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo pharmacologic activities of antisense oligonucleotides.
Mirabelli CK; Bennett CF; Anderson K; Crooke ST
Anticancer Drug Des; 1991 Dec; 6(6):647-61. PubMed ID: 1663361
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the stereocontrolled synthesis of antisense phosphorothioates.
Lu Y
Mini Rev Med Chem; 2006 Mar; 6(3):319-30. PubMed ID: 16515471
[TBL] [Abstract][Full Text] [Related]
35. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
36. Antisense strategies for oncogene inactivation.
Stein CA; Benimetskaya L; Mani S
Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
[TBL] [Abstract][Full Text] [Related]
37. Antisense oligonucleotides as a tool for gene functionalization and target validation.
Bennett CF; Cowsert LM
Biochim Biophys Acta; 1999 Dec; 1489(1):19-30. PubMed ID: 10806994
[No Abstract] [Full Text] [Related]
38. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
Delihas N; Rokita SE; Zheng P
Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
[TBL] [Abstract][Full Text] [Related]
39. Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.
Shen X; Corey DR
Nucleic Acids Res; 2018 Feb; 46(4):1584-1600. PubMed ID: 29240946
[TBL] [Abstract][Full Text] [Related]
40. Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Expert Opin Investig Drugs; 2008 Jul; 17(7):969-72. PubMed ID: 18549334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
